The North America Electrophoresis Reagents Market is projected to exhibit robust growth, driven by expanding applications in genomics and proteomics, increasing investments in life sciences research, and rising demand from biopharmaceutical and academic sectors. Valued at USD 425 million in 2025, it is expected to reach USD 910 million by 2035, growing at a CAGR of 7.2% from 2024 to 2035.
The economic impact of tariffs on "North America Electrophoresis Reagents Market".
Market Growth Drivers
Rising Genomic and Proteomic Research: The proliferation of genomic and proteomic studies, propelled by advanced research initiatives and increased government funding across North America, is a primary growth driver for electrophoresis reagents. Companies like Bio-Rad Laboratories have expanded their reagent portfolios to cater to high-throughput sequencing and molecular diagnostics, offering reliable and high-performance solutions to academic and industrial research centers.
Expansion of Biopharmaceutical Production: The surge in biopharmaceutical products such as monoclonal antibodies, vaccines, and biosimilars has escalated the need for precise analytical tools like electrophoresis reagents. Thermo Fisher Scientific, for instance, has introduced innovative reagents and kits aimed at enhancing the analysis of protein purity and ensuring regulatory compliance during drug development, thus fostering market growth.
Market Trends
Growth of Automated Electrophoresis Platforms: Automation in electrophoresis processes is a notable trend, with major companies such as Agilent Technologies introducing automated systems that increase throughput and reduce manual intervention. These platforms not only boost lab efficiency but also drive demand for compatible, ready-to-use electrophoresis reagents tailored for automated equipment.
Shift Toward Capillary Electrophoresis: Capillary electrophoresis is gaining traction for its speed, resolution, and minimal sample requirement. Companies like SCIEX continue to expand their reagent offerings compatible with advanced capillary electrophoresis instruments. This trend responds to a growing preference in clinical diagnostics and pharmaceutical research for sensitive and rapid analytical workflows.
Market Opportunity
Introduction of Multiplexing Reagents: The demand for multiplexing reagents, which allow simultaneous analysis of multiple biomarkers, presents new growth avenues. For example, GE Healthcare is focusing on expanding its line of multiplex reagents to address high-sensitivity clinical and research applications.
Expansion in Personalized Medicine: The growing precision medicine sector provides vast opportunities for electrophoresis reagent manufacturers. Tailored reagent solutions for detecting patient-specific genetic variations are being developed by companies such as Promega Corporation, expanding the market scope.
North America Electrophoresis Reagents Market Revenue (USD Million), 2020-2035
The chart illustrates the steady revenue growth of the North America Electrophoresis Reagents Market from 2020 to 2035. Beginning at USD 282 million in 2020, the market demonstrates a consistent upward trajectory driven by technological advancements, increasing biotech investments, and expanding application areas. The revenue surpasses USD 425 million by 2025 with a CAGR of 7.2%, reaching approximately USD 910 million by 2035. This progressive growth signifies rising demand from biopharmaceutical companies, research laboratories, and diagnostic centers across the region, underpinned by ongoing innovations in reagent formulations and automation.
North America Electrophoresis Reagents Market by Regions Share (%), 2025
The regional market share analysis for 2025 highlights the dominance of the United States, which holds 76% of the North American electrophoresis reagents market owing to major R&D investments, a strong presence of biotechnology companies, and extensive academic research. Canada accounts for 16%, benefiting from supportive government funding and growing biopharma activities. Mexico stands at 6%, showing increased interest in laboratory research, while Other Central America and Caribbean regions collectively represent 2%, driven mostly by niche academic projects. The United States remains the largest hub due to its comprehensive healthcare and life sciences infrastructure.
Recent Developments
In March 2024, Bio-Rad Laboratories launched a new line of next-generation agarose and polyacrylamide electrophoresis reagents, optimized for high-resolution protein and nucleic acid separation. This launch is aimed at increasing lab productivity for both genomics and proteomics customers across North America.
In April 2024, Thermo Fisher Scientific announced a strategic collaboration with a leading academic institution in the US to co-develop custom electrophoresis reagents for precision oncology applications. The partnership aims to address workflow gaps and introduce advanced reagents for targeted biomarker detection.
In May 2024, Agilent Technologies upgraded its automated capillary electrophoresis systems with a newly formulated reagent kit facilitating multiplex fluorescent detection. The innovation supports emerging needs in DNA analysis for clinical diagnostics and expands Agilent’s footprint in the North American market.
Press Releases